Literature DB >> 7363679

Lung biopsy specimens in the evaluation of pulmonary vascular disease.

C A Wagenvoort.   

Abstract

Open lung biopsy specimens in 72 patients were submitted for evaluation of pulmonary vascular disease. In nine instances, the specimens were inadequate for this purpose. Essentially, there were three indications for taking a lung biopsy specimen. The first was unexplained pulmonary hypertension with 40 patients in this category; plexogenic pulmonary arteriopathy was diagnosed in 14, and chronic pulmonary thromboembolism in 12. Others included pulmonary venoocclusive disease in two patients; two other patients had pulmonary vascular lesions in their lung biopsy specimens, indicative of chronic hypoxic pulmonary hypertension; and ten patients had severe arterial as well as venous alterations that could have been caused by obstruction to pulmonary venous flow as well as by fibrosis of lung tissue. Since we realized this possible source of error, we have submitted these two alternative possibilities to the clinician. In a heterogeneous group of eight patients, the nature of acquired or congenital heart disease remained doubtful in spite of extensive clinical investigation. In several instances, the biopsy specimen contributed to establishing the diagnosis of the cardiac condition. Finally, in a group of 15 patients with known congenital cardiac disease and pulmonary hypertension, whose state of pulmonary vasculature was considered borderline as far as the possibility of corrective surgery of the cardiac defect was concerned, lung biopsy specimens helped to determine the feasibility of surgery. The results show that in a restricted group of patients with pulmonary vascular disease, a biopsy of the lung has a place in establishing the nature and severity of the vascular alterations.

Entities:  

Mesh:

Year:  1980        PMID: 7363679     DOI: 10.1378/chest.77.5.614

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

Review 2.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 3.  The pulmonary circulation in children with congenital heart disease: morphologic and morphometric considerations.

Authors:  F A Burrows; M Rabinovitch
Journal:  Can Anaesth Soc J       Date:  1985-07

4.  Clinical correlates of angiographically diagnosed idiopathic pulmonary hypertension.

Authors:  H H Gray; J M Morgan; I H Kerr; G A Miller
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

5.  CHANGES IN PULMONARY VASCULATURE IN LUNG DISEASES WHICH LEAD TO PULMONARY HYPERTENSION.

Authors:  R B Batra; S K Basu
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension.

Authors:  M D Botney; M J Liptay; L R Kaiser; J D Cooper; W C Parks; R P Mecham
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis.

Authors:  Riitta Kaarteenaho-Wiik; Ylermi Soini
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479

8.  Imaging of pulmonary vascular disease by intravascular ultrasound.

Authors:  P J Scott; A R Essop; W al-Ashab; A Deaner; J Parsons; G Williams
Journal:  Int J Card Imaging       Date:  1993-09

Review 9.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

Review 10.  Thrombosis, platelets, microparticles and PAH: more than a clot.

Authors:  Katie L Lannan; Richard P Phipps; R James White
Journal:  Drug Discov Today       Date:  2014-04-18       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.